Table 4.
Item | Patients | 25-(OH)D (ng/mL) | PTH (pg/mL) | PINP (ng/mL) | β-CTX (ng/mL) | Osteocalcin (ng/mL) |
---|---|---|---|---|---|---|
NFS | ||||||
<-1.455 | 52 | 13.585±5.172 | 33.067±18.293 | 37.635±15.892 | 0.413±0.238 | 10.693±4.497 |
−1.455~0.676 | 128 | 14.496±6.599 | 35.783±21.926 | 34.836±11.297 | 0.312±0.142 | 10.456±3.730 |
>0.676 | 28 | 9.365±4.759*ΔΔ | 33.823±24.732 | 48.894±34.186 | 0.378±0.228 | 10.185±4.845 |
FLI | ||||||
<30 | 68 | 15.756±8.501 | 35.942±19.368 | 34.584±12.475 | 0.322±0.166 | 10.041±3.221 |
30~60 | 63 | 13.796±4.156 | 38.775±27.570 | 43.939±18.314 | 0.420±0.244 | 12.848±5.146* |
>60 | 77 | 11.713±5.961* | 31.755±17.604 | 32.461±10.729Δ | 0.307±0.150 | 8.909±2.654ΔΔ |
Notes: Compared with <-1.455, *P<0.05; >0.676 compared with −1.455~0.676, ΔP<0.05, ΔΔP<0.01; compared with <30, *P<0.05; >60 compared with 30~60, ΔP<0.05, ΔΔP<0.01. Results with statistical significance were marked in bold.
Abbreviations: NFS, NAFLD fibrosis score; FLI, fatty liver index.